{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T23:12:09Z","timestamp":1760915529257,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004004","name":"Universit\u00e0 degli Studi di Trento","doi-asserted-by":"publisher","award":["US 8,722,343 B2"],"award-info":[{"award-number":["US 8,722,343 B2"]}],"id":[{"id":"10.13039\/501100004004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.phrs.2022.106130","type":"journal-article","created":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T02:18:59Z","timestamp":1644459539000},"page":"106130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Autoantibodies against the glial glutamate transporter GLT1\/EAAT2 in Type 1 diabetes mellitus\u2014Clues to novel immunological and non-immunological therapies"],"prefix":"10.1016","volume":"177","author":[{"given":"Carla","family":"Perego","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana S.","family":"Di Cairano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Bazzigaluppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria Frolich","family":"Centonze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Gastaldelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Assi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Fiorina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Federici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottavia","family":"Porzio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto M.","family":"Davalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franco","family":"Folli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106130_bib1","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db10-1797","article-title":"How does Type 1 diabetes develop?: the notion of homicide or -cell suicide revisited","volume":"60","author":"Atkinson","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1172\/JCI0213605","article-title":"Multiple immuno-regulatory defects in type-1 diabetes","volume":"109","author":"Kukreja","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106130_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2337\/diabetes.53.2.267","article-title":"Autoimmune diabetes and the circle of tolerance","volume":"53","author":"Rossini","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006534","article-title":"Restoration of the unfolded protein response in pancreatic cells protects mice against Type 1 diabetes","volume":"5","author":"Engin","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.phrs.2022.106130_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2009.04087.x","article-title":"Islet inflammation and CXCL10 in recent-onset type 1 diabetes","volume":"159","author":"Roep","year":"2010","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.phrs.2022.106130_bib6","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","article-title":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies","volume":"2","author":"Bottazzo","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2022.106130_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/347151a0","article-title":"Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase","volume":"347","author":"Baekkeskov","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2022.106130_bib8","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.4049\/jimmunol.155.11.5419","article-title":"Identification of protein tyrosine phosphatase-like IA2 (islet cell antigen 512) as the insulin-dependent diabetes-related 37\/40K autoantigen and a target of islet-cell antibodies","volume":"155","author":"Bonifacio","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2022.106130_bib9","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1056\/NEJM198012253032601","article-title":"Cytotoxic autoantibodies to beta cells in the serum of patients with insulin-dependent diabetes mellitus","volume":"303","author":"Dobersen","year":"1980","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2022.106130_bib10","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/db15-1058","article-title":"Identification of tetraspanin-7 as a target of autoantibodies in Type 1 diabetes","volume":"65","author":"McLaughlin","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib11","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.6362005","article-title":"Insulin antibodies in insulin-dependent diabetics before insulin treatment","volume":"222","author":"Palmer","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.phrs.2022.106130_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni.1844","article-title":"Chromogranin A is an autoantigen in type 1 diabetes","volume":"11","author":"Stadinski","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2022.106130_bib13","doi-asserted-by":"crossref","first-page":"17040","DOI":"10.1073\/pnas.0705894104","article-title":"The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes","volume":"104","author":"Wenzlau","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2022.106130_bib14","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1172\/JCI116431","article-title":"Demonstration of GAD-65 as the main immunogenic isoform of glutamate decarboxylase in type 1 diabetes and determination of autoantibodies using a radioligand produced by eukaryotic expression","volume":"91","author":"Velloso","year":"1993","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.phrs.2022.106130_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diab.34.9.855","article-title":"Cytotoxic islet cell surface antibodies (ICSA) in patients with type I diabetes and their first-degree relatives","volume":"34","author":"Toguchi","year":"1985","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib16","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/diab.38.1.S82","article-title":"Islet cell surface antibodies from insulin-dependent diabetics bind specifically to pancreatic B cells","volume":"70","author":"Bosi","year":"1989","journal-title":"Diabetes"},{"issue":"16","key":"10.1016\/j.phrs.2022.106130_bib17","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1056\/NEJM198804213181602","article-title":"Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus","volume":"318","author":"Solimena","year":"1988","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2022.106130_bib18","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/j.1460-2075.1991.tb08069.x","article-title":"GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion","volume":"10","author":"Reetz","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2022.106130_bib19","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJM199005313222202","article-title":"Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome","volume":"322","author":"Solimena","year":"1990","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2022.106130_bib20","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1523\/JNEUROSCI.14-09-05559.1994","article-title":"Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex","volume":"14","author":"Arriza","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2022.106130_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/360467a0","article-title":"Primary structure and functional characterization of a high-affinity glutamate transporter","volume":"360","author":"Kanai","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2022.106130_bib22","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1046\/j.1471-4159.2000.0751076.x","article-title":"The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures","volume":"75","author":"Perego","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2022.106130_bib23","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/360464a0","article-title":"Cloning and expression of a rat brain L-glutamate transporter","volume":"360","author":"Pines","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2022.106130_bib24","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1073\/pnas.89.22.10955","article-title":"Structure, expression, and functional analysis of a Na(+)-dependent glutamate\/aspartate transporter from rat brain","volume":"89","author":"Storck","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2022.106130_bib25","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0896-6273(00)80086-0","article-title":"Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate","volume":"16","author":"Rothstein","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2022.106130_bib26","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1126\/science.276.5319.1699","article-title":"Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1","volume":"276","author":"Tanaka","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.phrs.2022.106130_bib27","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1074\/jbc.M206758200","article-title":"Secretory granule-mediated co-secretion of L-glutamate and glucagon triggers glutamatergic signal transmission in islets of Langerhans","volume":"278","author":"Hayashi","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2022.106130_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00592-011-0364-z","article-title":"The potential role of glutamate in the current diabetes epidemic","volume":"49","author":"Davalli","year":"2012","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.phrs.2022.106130_bib29","doi-asserted-by":"crossref","first-page":"14007","DOI":"10.1074\/jbc.M110.183517","article-title":"The glial glutamate transporter 1 (GLT1) is expressed by pancreatic beta-cells and prevents glutamate-induced beta-cell death","volume":"286","author":"Di Cairano","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2022.106130_bib30","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/jcp.25176","article-title":"Neurotransmitters and neuropeptides: new players in the control of islet of Langerhans\u2019 cell mass and function","volume":"231","author":"Di Cairano","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2022.106130_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.tem.2015.12.004","article-title":"Exciting times for pancreatic islets: glutamate signaling in endocrine cells","volume":"27","author":"Otter","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2022.106130_bib32","doi-asserted-by":"crossref","first-page":"9037","DOI":"10.1073\/pnas.85.23.9037","article-title":"Beta-cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene","volume":"85","author":"Efrat","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.phrs.2022.106130_bib33","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","article-title":"Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes","volume":"59","author":"Richardson","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2022.106130_bib34","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0140-6736(80)92825-1","article-title":"Complement-fixing islet-cell antibodies in type-I diabetes: possible monitors of active beta-cell damage","volume":"1","author":"Bottazzo","year":"1980","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.phrs.2022.106130_bib35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/diab.40.8.977","article-title":"Progression to type I diabetes in autoimmune endocrine patients with islet cell antibodies","volume":"40","author":"Bosi","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib36","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0140-6736(88)91601-7","article-title":"Predicting insulin-dependent diabetes","volume":"1","author":"Tarn","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2022.106130_bib37","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/glia.22354","article-title":"Cell surface turnover of the glutamate transporter GLT-1 is mediated by ubiquitination\/deubiquitination","volume":"60","author":"Mart\u00ednez-Villarreal","year":"2012","journal-title":"Glia"},{"key":"10.1016\/j.phrs.2022.106130_bib38","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2022.106130_bib39","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1210\/edrv-9-1-106","article-title":"Autoantibodies to the thyrotropin receptor","volume":"9","author":"Rees Smith","year":"1988","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.phrs.2022.106130_bib40","first-page":"1242","article-title":"Low molecular weight follicle-stimulating hormone receptor binding inhibitor in sera from premature ovarian failure patients","volume":"74","author":"Sluss","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2022.106130_bib41","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1038\/mp.2016.125","article-title":"All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class","volume":"22","author":"Castillo-G\u00f3mez","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2022.106130_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1600-065X.2012.01144.x","article-title":"Neural antigen-specific autoimmune disorders","volume":"248","author":"Iorio","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2022.106130_bib43","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrcardio.2017.61","article-title":"Autoimmune channelopathies as a novel mechanism in cardiac arrhythmias","volume":"14","author":"Lazzerini","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2022.106130_bib44","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(89)90893-3","article-title":"Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome","volume":"2","author":"Sher","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2022.106130_bib45","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0140-6736(90)90248-4","article-title":"Calcium channel autoantibody and non-small-cell lung cancer in patients with Lambert-Eaton syndrome","volume":"335","author":"Sher","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2022.106130_bib46","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"key":"10.1016\/j.phrs.2022.106130_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s00125-020-05298-y","article-title":"Presumption of guilt for T cells in type 1 diabetes: lead culprits or partners in crime depending on age of onset?","volume":"64","author":"Carr\u00e9","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2022.106130_bib48","first-page":"2940","article-title":"Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus","volume":"21","author":"Garcia-Contreras","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2022.106130_bib49","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.3390\/ijms20235903","article-title":"Profiling of RNAs from human islet-derived exosomes in a model of Type 1 diabetes","volume":"20","author":"Krishnan","year":"2019","journal-title":"IJMS"},{"key":"10.1016\/j.phrs.2022.106130_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/db16-0671","article-title":"Primary human and rat \u03b2-cells release the intracellular autoantigens GAD65, IA-2, and proinsulin in exosomes together with cytokine-induced enhancers of immunity","volume":"66","author":"Cianciaruso","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib51","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1210\/en.2018-00649","article-title":"Immune response to extracellular vesicles from human islets of langerhans in patients with Type 1 diabetes","volume":"159","author":"Rutman","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.phrs.2022.106130_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202000053","article-title":"Pancreatic tissue proteomics unveils key proteins, pathways, and networks associated with Type 1 diabetes","volume":"14","author":"Woo","year":"2020","journal-title":"Prot. Clin. Appl."},{"key":"10.1016\/j.phrs.2022.106130_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41582-020-0400-0","article-title":"Complement in neurological disorders and emerging complement-targeted therapeutics","volume":"16","author":"Dalakas","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.phrs.2022.106130_bib54","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/imm.12674","article-title":"Elevated systemic glutamic acid level in the non-obese diabetic mouse is Idd linked and induces beta cell apoptosis","volume":"150","author":"Banday","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2022.106130_bib55","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1084\/jem.20081800","article-title":"Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes","volume":"205","author":"Oresic","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2022.106130_bib56","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/BF00505179","article-title":"Seasonality of type 1 (insulin-dependent) diabetes mellitus: values of C-peptide, insulin antibodies and haemoglobin A1c show evidence of a more rapid loss of insulin secretion in epidemic patients","volume":"32","author":"Ludvigsson","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2022.106130_bib57","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-cell mass in the natural history of Type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib58","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production and pancreatic -cell turnover after 50 years of diabetes: Joslin medalist study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.phrs.2022.106130_bib59","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.2337\/dc13-0203","article-title":"Increased complement activation in human Type 1 diabetes pancreata","volume":"36","author":"Rowe","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.phrs.2022.106130_bib60","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1172\/JCI127397","article-title":"Residual \u03b2 cell function and monogenic variants in long-duration type 1 diabetes patients","volume":"129","author":"Yu","year":"2019","journal-title":"J. Clin. Investig."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822000755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:36:44Z","timestamp":1760913404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822000755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":60,"alternative-id":["S1043661822000755"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106130","relation":{},"ISSN":["1043-6618"],"issn-type":[{"type":"print","value":"1043-6618"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies against the glial glutamate transporter GLT1\/EAAT2 in Type 1 diabetes mellitus\u2014Clues to novel immunological and non-immunological therapies","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106130"}}